News
1 minute read

MBHB Partner Kevin Noonan Quoted in Life Sciences IP Review Article Entitled, “The Future of Sovereign Immunity Deals after Allergan Ruling”

Kevin E. Noonan, Ph.D.January 3, 2018

McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. is quoted in a January 3, 2018 Life Sciences IP Review article entitled, “The future of sovereign immunity deals after Allergan ruling.” Late last week, the Patent Trial and Appeal Board (PTAB) rejected a Native American tribe’s attempt to dismiss inter partes reviews (IPRs) based on the tribe’s sovereign immunity claims. view the article